Luke Pike
Director, Brain Radiation Oncology · New York Presbyterian Hospital
Credentials: · · · · ·
History
- 2022–Present
Memorial Sloan Kettering Cancer Center · Memorial Sloan Kettering Monmouth
- 2015–2016
Preliminary or Transitional Year
2011–2015
Research
Regulation of autophagy by ATF4 in response to severe hypoxia
Oncogene · 2010 · 330 citations
Cancer Research · 2009 · 265 citations
Safety of combining radiotherapy with immune-checkpoint inhibition
Review · Nature Reviews Clinical Oncology · 2018 · 253 citations
- BI
25 papers · 3 as a fellow
- NM
16 papers
- YY
12 papers

10 papers

9 papers

8 papers · 8 as a resident
- KB
8 papers
- BL
6 papers
Grants
- 2026–2031
Digital Physical Activity in Individuals Living with Metastatic Cancer
National Cancer Institute · R01
PI · $751.6K · Sloan-Kettering Inst Can Research
Clinical trials
- 2026–2028
Principal investigator · Recruiting
Memorial Sloan Kettering Cancer Center
- 2026–2028
Principal investigator · Recruiting · Phase 1, Phase 2
Memorial Sloan Kettering Cancer Center
- 2025–2027
Prospective Study to Assess a Diagnostic Aid for Cancer
Principal investigator · Recruiting
Harbinger Health
- 2024–2027
Principal investigator · Recruiting · Phase 2
Memorial Sloan Kettering Cancer Center


